Combined statin-fibrate therapy-induced rhabdomyolysis: Case report
Introduction Rhabdomyolysis is a rare, but serious and potentially fatal adverse reaction of the statin application that may be developed in any time of therapy. It is characterized by massive destruction of muscles associated with the large increase of creatine kinase (CK) leading to myoglobinuria...
Saved in:
Main Authors: | Jozić Tanja L. (Author), Terzić Branka M. (Author), Mitrović Predrag M. (Author), Kostić Jasminka D. (Author), Milanov Marko Z. (Author), Stojanović Milena M. (Author), Ašanin Milika R. (Author) |
---|---|
Format: | Book |
Published: |
Srpsko lekarsko drustvo,
2014-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanism of Statin-Induced Rhabdomyolysis
by: Kazuho Sakamoto, et al.
Published: (2013) -
The self-limiting nature of statin-induced rhabdomyolysis
by: Abdulsalam A Al-Sulaiman, et al.
Published: (2009) -
Safety of Combined Statin and Fibrate Therapy: Risks of Liver Injury and Acute Kidney Injury in a Cohort Study from the Shizuoka Kokuho Database
by: Yohei Sobukawa, et al.
Published: (2024) -
Hypolipidemic Mechanisms of Ananas comosus L. Leaves in Mice: Different From Fibrates but Similar to Statins
by: Weidong Xie, et al.
Published: (2007) -
Ascorbic Acid Significantly Decreases Creatine Kinase Plasma Levels in an Animal Model of Statin/Fibrate-Induced Myopathy
by: Mohsen Zabihi, et al.
Published: (2021)